We are live on ! Find out more
Viking Global Investors

Viking Global Investors Portfolio holdings

AUM $35.7B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+21.3%
3 Year Est. Return
+91.13%
5 Year Est. Return
+89.39%
10 Year Est. Return
+464.55%
AUM
$14.8B
AUM Growth
-$7.79B
Cap. Flow
-$8.63B
Cap. Flow %
-58.13%
Top 10 Hldgs %
55.06%
Holding
80
New
16
Increased
15
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$659M
2
V icon
Visa
V
+$335M
3
APC
Anadarko Petroleum
APC
+$210M
4
CRM icon
Salesforce
CRM
+$186M
5
AFL icon
Aflac
AFL
+$160M

Sector Composition

Rank Sector Weight
1 Communication Services 19.48%
2 Technology 17.58%
3 Healthcare 13.31%
4 Industrials 12.69%
5 Financials 11.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFL icon
26
Aflac
AFL
$63.4B
$166M 1.12%
+4,267,608
New +$160M
BABA icon
27
Alibaba
BABA
$308B
$155M 1.04%
+1,100,913
New +$136M
JAZZ icon
28
Jazz Pharmaceuticals
JAZZ
$16.7B
$154M 1.04%
992,901
+795,071
+402% +$122M
TDG icon
29
TransDigm Group
TDG
$67.7B
$144M 0.97%
+533,860
New +$136M
NUVA
30
DELISTED
NuVasive, Inc.
NUVA
$138M 0.93%
1,800,463
+567,931
+46% +$42.5M
SHPG
31
DELISTED
Shire pic
SHPG
$132M 0.89%
797,053
+11,288
+1% +$1.97M
MOH icon
32
Molina Healthcare
MOH
$10.3B
$102M 0.69%
+1,476,832
New +$90.6M
XRAY icon
33
Dentsply Sirona
XRAY
$2.43B
$92.7M 0.62%
1,430,369
+575,971
+67% +$36.4M
GWPH
34
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$87.5M 0.59%
873,308
+38,703
+5% +$4.17M
HUM icon
35
Humana
HUM
$46.2B
$83.2M 0.56%
345,907
-94,859
-22% -$21.5M
DD icon
36
DuPont de Nemours
DD
$19.2B
$79.7M 0.54%
498,973
-4,769,656
-91% -$758M
RJF icon
37
Raymond James Financial
RJF
$34B
$76.7M 0.52%
+1,434,477
New +$72.2M
AVXS
38
DELISTED
AveXis, Inc. Common Stock
AVXS
$73.4M 0.49%
893,258
+511,632
+134% +$38.4M
CPAY icon
39
Corpay
CPAY
$25.7B
$68.5M 0.46%
+474,690
New +$67.8M
NSC icon
40
Norfolk Southern
NSC
$75.1B
$57.2M 0.39%
+470,075
New +$55.2M
LOW icon
41
Lowe's Companies
LOW
$125B
$57.1M 0.38%
+736,048
New +$60.2M
MRSH
42
Marsh
MRSH
$91.5B
$54.4M 0.37%
+698,142
New +$52.7M
ELV icon
43
Elevance Health
ELV
$85.5B
$53.9M 0.36%
+286,680
New +$51.5M
ZBH icon
44
Zimmer Biomet
ZBH
$18.4B
$51.1M 0.34%
+409,584
New +$48.6M
KITE
45
DELISTED
Kite Pharma, Inc.
KITE
$49.8M 0.34%
+480,155
New +$39.2M
EXPE icon
46
Expedia Group
EXPE
$37.3B
$47.7M 0.32%
+319,974
New +$44.9M
HDB icon
47
HDFC Bank
HDB
$121B
$39.3M 0.26%
1,806,216
+50,664
+3% +$1.06M
XOG
48
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$38.2M 0.26%
2,839,191
+134,559
+5% +$2.1M
CALA
49
DELISTED
Calithera Biosciences, Inc
CALA
$35.9M 0.24%
121,016
+5,735
+5% +$1.53M
EDIT icon
50
Editas Medicine
EDIT
$442M
$28.7M 0.19%
1,709,401

Similar funds

Viking Global Investors's Q2 2017 Portfolio in Review

As of Q2 2017, Viking Global Investors held 80 positions worth $14.8B, down 34% from $22.6B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Viking Global Investors withdrew a net $8.63B in Q2 2017, closing 27 positions and reducing 20 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $892M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 19% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Viking Global Investors opened a new position in Wells Fargo worth $681M.

  • Viking Global Investors's largest Q2 2017 buy was Wells Fargo: 12,297,209 shares worth $681M.
  • Viking Global Investors added most to Visa in Q2 2017, an estimated $335M increase.
  • Viking Global Investors's biggest Q2 2017 reduction was Meta Platforms (Facebook), cutting an estimated $1.42B.
  • Viking Global Investors fully exited Alphabet (Google) Class C in Q2 2017, selling an estimated $892M.
  • Viking Global Investors's ten largest holdings make up 55% of its $14.8B portfolio in Q2 2017.
  • Viking Global Investors opened 16 new positions and closed 27 in Q2 2017.
  • Viking Global Investors's portfolio value fell 34% quarter-over-quarter to $14.8B.

Based on Viking Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.